OABI

OABI R&D to Revenue

255.83%Fiscal year

Period ending:

OABI FY R&D/Revenue%
OABI FY R&D/Revenue277.88%50.06%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

OABI r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Omniab Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
255.8341%
208.8212%
165.4519%
81.866%
112.9043%
106.567%
72.1039%

Compare r&d to revenue

All OABI financial metrics · OABI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.